In 2024, China's status as an overseas exporter of Albendazole involved a significant number of shipments, particularly for Albendazole USP, with strong import growth from China observed in the global market. While Albendazole Suspension export data shows China as a major player, the most significant export market is India for Tablets, with China holding a smaller market share for that form.
China's Albendazole USP industry shows strong export activity, as evidenced by a substantial 59% growth rate in global imports of Albendazole USP from China between September 2023 and August 2024.
China exported 176 shipments of Albendazole Suspension as of June 2025, making it the second-largest exporter in this category, trailing only India.
China's contribution to the global export of Albendazole Tablets is relatively small, with only 29 shipments recorded, securing about a 1% market share in this category. India is the dominant exporter for this form of Albendazole.